Development of Capsule containing Immediate Release Tablet and Extended Release Floating Tablet for Monitoring Release of Atenolol

Atenolol is beta blocker absorbed through GIT use for heart diseases. Single tablets, floating tablets and sustained released formulations studied are insufficient to produce effective dose to enhance bioavailability and effectiveness. Our study is focused on development of capsule dosage form conta...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Research journal of pharmacy and technology 2021-04, Vol.14 (4), p.2216-2220
Hauptverfasser:	Kolhe, Mahesh Hari, Gilhotra, Ritu Mehra, Asane, Govind Sarangdhar
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioavailability Drug dosages Heart rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!